Cardiovascular diseases crossroads: cGAS-STING signaling and disease progression

MS Khan, SU Khan, SU Khan, M Suleman… - Current Problems in …, 2023 - Elsevier
It is now widely accepted that inflammation is critical in cardiovascular diseases (CVD).
Here, studies are being conducted on how cyclic GMP-AMP synthase (cGAS), a component …

Beyond the beat: A pioneering investigation into exercise modalities for alleviating diabetic cardiomyopathy and enhancing cardiac health

AR Khan, MAH Alnoud, H Ali, I Ali, S Ahmad… - Current Problems in …, 2023 - Elsevier
Patients with preexisting cardiovascular disease or those at high risk for developing the
condition are often offered exercise as a form of therapy. Patients with cancer who are at an …

Single-cell RNA Sequencing (scRNA-seq): Advances and Challenges for Cardiovascular Diseases (CVDs)

SU Khan, Y Huang, H Ali, I Ali, S Ahmad… - Current Problems in …, 2023 - Elsevier
Implementing Single-cell RNA sequencing (scRNA-seq) has significantly enhanced our
comprehension of cardiovascular diseases (CVDs), providing new opportunities to …

Heartfelt living: deciphering the link between lifestyle choices and cardiovascular vitality

X Jiang, MAH Alnoud, H Ali, I Ali, T Hussain… - Current Problems in …, 2024 - Elsevier
Cardiovascular diseases (CVDs) are still leading to a significant number of deaths
worldwide despite the remarkable advancements in medical technology and pharmacology …

AMPK signalling pathway: a potential strategy for the treatment of heart failure with Chinese medicine

C Liu, X Guo, Y Zhou, H Wang - Journal of inflammation research, 2023 - Taylor & Francis
Heart failure (HF) is a complex clinical syndrome that represents the advanced stage of
cardiovascular disease, characterized by systolic and diastolic dysfunction of the heart …

Cardiovascular challenges in the era of antiretroviral therapy for AIDS/HIV: A comprehensive review of research advancements, pathophysiological insights, and …

M Suleman, SU Khan, T Hussain, MU Khan… - Current problems in …, 2024 - Elsevier
Cardiovascular disease, particularly coronary heart disease, is becoming more common
among those living with HIV. Individuals with HIV face an increased susceptibility to …

Journey into tomorrow: cardiovascular wellbeing transformed by nano-scale innovations

AY Safhi, AH Albariqi, FY Sabei, A Alsalhi… - Current Problems in …, 2024 - Elsevier
Worldwide, cardiovascular diseases (CVDs) account for the vast majority of deaths and
place enormous financial strains on healthcare systems. Gold nanoparticles, quantum dots …

Nano Revolution in Cardiovascular Health: Nanoparticles (NPs) as Tiny Titans for Diagnosis and Therapeutics

J Abid, FMA Khalil, S Saeed, SU Khan, I Iqbal… - Current Problems in …, 2024 - Elsevier
Cardiovascular diseases (CVDs) are known as life-threatening illnessescaused by severe
abnormalities in the cardiovascular system. They are a leading cause of mortality and …

Beyond the silence: A comprehensive exploration of long non-coding RNAs as genetic whispers and their essential regulatory functions in cardiovascular disorders

Y Xiong, MAH Alnoud, H Ali, I Ali, S Ahmad… - Current Problems in …, 2024 - Elsevier
Long non-coding RNAs (lncRNAs) are RNA molecules that regulate gene expression at
several levels, including transcriptional, post-transcriptional, and translational. They have a …

Nano Guardians of the Heart: A Comprehensive Investigation into the Impact of Silver Nanoparticles on Cardiovascular Physiology

AA Alshihri, SU Khan, SS ul Hassan… - Current Problems in …, 2024 - Elsevier
Globally, cardiovascular diseases (CVDs) constitute the leading cause of death at the
moment. More effective treatments to combat CVDs are urgently required. Recent advances …